This site is intended for
US
Healthcare Professionals only.
ICOS
- ICOS is an activating receptor from the CD28 superfamily1-5
- ICOS is expressed on activated cytotoxic T cells, regulatory T cells (Tregs)
,
NK cells, and other types of T cells1-5
- ICOSL (B7RP-1), the ligand for ICOS, is expressed on antigen-presenting cells
(APCs)such as dendritic cells (DCs) and macrophages1,2,4
- While similar in structure to the cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor, ICOS has a distinctly opposing function: ICOS/ICOSL signaling leads to the activation, proliferation, and survival of cytotoxic T cells, as well as memory T-cell survival2,6-9
- Following T-cell activation, ICOS upregulation perpetuates T-cell proliferation and function7,10
- ICOS/ICOSL signaling may also enhance activated NK-cell function5
- Mouse models show that ICOS expression augments the antitumor response of NK cells5
- In preclinical studies, ICOS signaling enhanced the activation, proliferation, and function of cytotoxic T cells11,12
- ICOS stimulation in combination with other checkpoint inhibitors was shown to enhance T-cell activity11
Get I-O Resources
Order or download
educational tools for your
patients and practice
REFERENCES–ICOS
1. Harada H, Salama AD, Sho M, et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest. 2003;112(2):234-243. 2. Zheng J, Chan P-L, Li u Y, et al. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner. PLoS One. 2013;8(12):e82203. doi:10.1371/journal.pone.0082203. 3. Tu J-F, Ding Y-H, Ying X-H, et al. Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival. Sci Rep. 2016;6:35056. doi:10.1038/srep35056. 4. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515-548. 5. Ogasawara K, Yoshinaga SK, Lanier LL. Inducible costimulator costimulates cytotoxic activity and IFN-γ production in activated murine NK cells. J Immunol. 2002;169(7):3676-3685. 6. Burmeister Y, Lischke T, Dahler AC, et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol. 2008;180(2):774-782. 7. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397(6716):263-266. 8. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell